| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f9db723f41b9245df17b048ca637ad2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2008-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_221102230855f9ae84703ec5f67a6024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e80d79d20a3cd9850ffbf2c03388e0b9 |
| publicationDate |
2009-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2127641-A1 |
| titleOfInvention |
Micronisable form of salmeterol xinafoate |
| abstract |
The present invention relates to micronisable salmeterol xinafoate polymorph I characterized by a mean particle size of between 5 and 15 µm and a bulk density between 0.1 and 0.2 g/mL, to a method for its preparation and to its use in the preparation of micronised salmeterol xinafoate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013064870-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011145109-A1 |
| priorityDate |
2008-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |